钠-葡萄糖共转运蛋白2抑制剂在非酒精性脂肪肝治疗中的最新进展

{"title":"钠-葡萄糖共转运蛋白2抑制剂在非酒精性脂肪肝治疗中的最新进展","authors":"Gehan Heeba, Mohamed Abolnaga, Eman Othman","doi":"10.21608/bfsa.2023.301257","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":55311,"journal":{"name":"Bulletin of Pharmaceutical Sciences","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"RECENT APPROACHES FOR SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS IN THE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE\",\"authors\":\"Gehan Heeba, Mohamed Abolnaga, Eman Othman\",\"doi\":\"10.21608/bfsa.2023.301257\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":55311,\"journal\":{\"name\":\"Bulletin of Pharmaceutical Sciences\",\"volume\":\"17 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin of Pharmaceutical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/bfsa.2023.301257\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/bfsa.2023.301257","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}